At close: 7:31 PM GMT+1
Loading Chart for R9U2.DU
DELL
- Previous Close
8.55 - Open
8.58 - Bid --
- Ask --
- Day's Range
8.55 - 8.85 - 52 Week Range
7.18 - 14.22 - Volume
0 - Avg. Volume
16 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 26, 2025 - Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: R9U2.DU
View MorePerformance Overview: R9U2.DU
Trailing total returns as of 11/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
R9U2.DU
12.84%
S&P/TSX Composite index
21.61%
1-Year Return
R9U2.DU
4.32%
S&P/TSX Composite index
26.79%
3-Year Return
R9U2.DU
56.29%
S&P/TSX Composite index
20.65%
5-Year Return
R9U2.DU
67.75%
S&P/TSX Composite index
49.62%
Compare To: R9U2.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
8.86
+3.57%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1120
+8.53%
Mkt Cap EUR 56.21M
Industry Drug Manufacturers—Specialty & Generic
3.6600
-2.40%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
6.45
-4.44%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0740
0.00%
Mkt Cap EUR 24.6M
Industry Drug Manufacturers—Specialty & Generic
1.4800
+2.78%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1119
+8.43%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.7200
-6.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.60
0.00%
Mkt Cap EUR 1.095B
Industry Drug Manufacturers—Specialty & Generic
4.1540
-3.17%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0210
-9.48%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: R9U2.DU
View MoreValuation Measures
As of 11/26/2024
Market Cap
2.08B
Enterprise Value
2.42B
Trailing P/E
33.07
Forward P/E
16.98
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.91
Price/Book (mrq)
1.19
Enterprise Value/Revenue
2.26
Enterprise Value/EBITDA
6.73
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--